PT Mitra Keluarga Karyasehat Tbk owns and operates a network of hospitals in Indonesia, primarily located on Java, and also provides healthcare platform services.
Sector: Healthcare
ID_MIKA
Net debt (table and EV/EBITDA): |short-term borrowings| + |long-term borrowings| + |other financial liabilities| when extracted + |non-controlling interest| when extracted − |cash and equivalents|; amounts in millions of the reporting currency.
Shares: connector/market_inputs
Monetary columns are in B IDR, one decimal; scale (K/M/B/T) keeps values readable. For the period (default) shows P&L and cash flow for that row’s reporting window: quarterly amounts when the feed uses quarter-duration facts (typical US 10-Q revenue and income), quarterly cash flows after stripping YTD where only cumulative tags exist, and an implied Q4 on 31 Dec FY rows (P&L: FY minus Q1–Q3; operating / investing cash flow: FY 12m minus 9M YTD to 30 Sep when sourced from SEC builder evidence) so they match 10-Q scale. Some issuers still use cumulative YTD minus the prior row in the same calendar year. As reported shows values stored on each row (e.g. full-year on FY). Balance sheet is always as reported. Source JSON may use millions etc.; conversion uses amounts_unit per row.
| Date | Period | Status | RevenueB IDR | Operating profitB IDR | D&AB IDR | EBITDAB IDR | Net profitB IDR | Operating CFB IDR | Capex + M&AB IDR | AssetsB IDR | EquityB IDR | ROE (annualized) | Net debtB IDR | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Q2 2026 (3M) | OK | 1412.4 y/y 8.0% | 453.0 y/y 7.0% | 97.8 y/y 15.4% | 550.8 y/y 8.4% | 383.3 y/y 6.5% | 435.5 | -298.2 | 9983.1 y/y 11.1% | 7306.5 y/y 11.7% | 19.6% | -2843.2 | Report (PDF) |
| 2026-03-31 | Q1 2026 (3M) | OK | 1356.5 y/y 6.6% | 408.3 y/y 4.4% | 94.3 y/y 20.4% | 502.6 y/y 7.1% | 345.0 y/y 3.8% | 447.6 | -237.7 | 9645.0 y/y 10.5% | 7578.7 y/y 11.3% | 18.6% | -2069.4 | Report (PDF) |
| 2025-12-31 | Q4 2025 (3M) | OK | 1387.8 y/y 10.5% | 426.2 y/y 10.4% | 91.3 y/y 7.0% | 517.5 y/y 9.8% | 359.7 y/y 23.8% | 601.6 | — | 9266.3 y/y 12.4% | 7254.6 y/y 11.7% | 20.3% | -2530.8 | Report (PDF) |
| 2025-09-30 | Q3 2025 (3M) | OK | 1417.0 y/y 10.0% | 476.5 y/y 14.2% | 87.2 y/y 12.0% | 563.7 y/y 13.8% | 398.6 y/y 15.6% | 594.9 | — | 8928.7 y/y 12.8% | 6920.8 y/y 11.2% | 21.4% | -1921.5 | Report (PDF) |
| 2025-06-30 | Q2 2025 (3M) | OK | 1291.3 y/y 4.5% | 414.0 y/y 3.5% | 88.2 y/y 12.1% | 502.2 y/y 4.9% | 351.4 y/y 6.0% | 301.1 | — | 8989.0 y/y 11.5% | 6540.4 y/y 9.9% | 20.5% | -2239.7 | Report (PDF) |
| 2025-03-31 | Q1 2025 (3M) | OK | 1272.2 y/y — | 391.2 y/y — | 78.3 y/y — | 469.5 y/y — | 332.2 y/y — | 437.2 | -208.6 | 8731.1 y/y — | 6809.4 y/y — | 20.0% | -1747.0 | Report (PDF) |
| 2024-12-31 | Q4 2024 (3M) | PARTIAL | 1255.4 y/y — | 386.2 y/y — | 85.3 y/y — | 471.5 y/y — | 290.6 y/y — | — | — | 8247.2 y/y — | 6497.3 y/y — | 19.3% | -1066.0 | Report (PDF) |
| 2024-09-30 | Q3 2024 (3M) | PARTIAL | 1166.5 y/y — | 344.5 y/y — | 78.0 y/y — | 422.6 y/y — | 291.5 y/y — | — | — | 7914.9 y/y — | 6222.0 y/y — | 20.5% | -1482.1 | Report (PDF) |
| 2024-06-30 | Q2 2024 (3M) | PARTIAL | 2452.5 y/y — | 777.9 y/y — | 148.6 y/y — | 926.5 y/y — | 645.0 y/y — | — | — | 8059.9 y/y — | 5949.7 y/y — | — | -1713.1 | Report (PDF) |
| Short-term debt (incl. ST leases) | 1 251 |
| Long-term debt (incl. LT leases) | 8 043 |
| − Cash & equivalents | 2 852 487 |
| Net debt | -2 843 193 |
|---|
Net debt / LTM EBITDA: -1.3x
Quarterly values (Rp mln)
Year-over-year change
Operating and investing cash flow (OCF + ICF) (Rp mln)
Net debt / cash (Rp mln)
| year | 2024 | 2025 |
|---|---|---|
| cash flow / profit | 1.41x | 1.34x |
| accruals, % of assets | -6.1% | -5.3% |
Our earnings breakdowns and investment notes on this issuer.
| USD/IDR | 18183 |
| 1-week | +1.1% |
| 1-month | +1.1% |
| room to 52w-weakest | 0.0% |
| DXY (dollar index) | 102.3 |
| US 10Y | 5.02% |
A weaker rupiah lowers the USD value of Indonesian equities for a foreign holder; for banks, BI's high policy rate (defending the currency) pressures margins.
as of 2026-10-28 (Yahoo)
Value the company creates per year, as a % of market cap
Value created per year: +9.3%
| 1. EBITDA growth (latest quarter YoY, annualised) [EBITDA latest qtr − EBITDA year-ago qtr] × annualisation X = — | 81 721 |
| 2. Current EV/EBITDA (LTM) (Market cap + Net debt) ÷ EBITDA (LTM) = (19 307 835 + -2 843 193) ÷ 2 134 583 | 7.7x |
| 3. Target multiple (Current EV/EBITDA + 9) ÷ 2 = (7.7 + 9) ÷ 2 | 8.4x |
| 4. Cash flow (balance method, LTM) Net-debt reduction + dividends + buybacks − equity issuance = 603 493 + 0 + 0 − 0 | 1 103 607 |
| 5. Value created per year (EBITDA growth × Target multiple + Cash flow − Dilution) ÷ Market cap = (81 721 × 8.4 + 1 103 607) ÷ 19 307 835 | +9.3% |
Amounts in millions of the reporting currency. EBITDA growth is the latest quarter vs the same quarter a year ago, annualised.
Caveats:
Group: Healthcare. Each peer is shown as it trades and re-priced onto this company's market (Indonesia) by the ratio of our coverage medians.
| Company | Market | Cap, $bn | EV/EBITDA | EV/EBITDA, adjusted |
|---|---|---|---|---|
| Merck & Co., Inc. | US | 355.5 | 14.9x | 3.8x |
| UNITEDHEALTH GROUP INC | US | 371.7 | 15.2x | 3.8x |
| AMGEN INC | US | 242.8 | 17.8x | 4.5x |
| Netcare | South Africa | 1.3 | 5.1x | 5.1x |
| Life Healthcare | South Africa | 1.1 | 5.9x | 5.9x |
| AbbVie Inc. | US | 507.8 | 24.5x | 6.2x |
| JOHNSON & JOHNSON | US | 646.9 | 25.7x | 6.5x |
| United Medical Group | Russia | 0.7 | 4.6x | 6.5x |
| THERMO FISHER SCIENTIFIC INC. | US | 260.7 | 27.0x | 6.8x |
| ELI LILLY & Co | US | 1149.2 | 33.5x | 8.4x |
| Promomed | Russia | 1.1 | 6.4x | 9.2x |
| MD Medical | Russia | 1.2 | 7.1x | 10.2x |
| Group median | 15.0x | 6.3x | ||
| Group average | 15.6x | 6.4x | ||
| This company | Indonesia | 1.1 | 7.7x | 7.7x |
Group median 15.0x as traded, 6.3x adjusted; this company 7.7x — a 22% premium.
Group average 15.6x as traded, 6.4x adjusted; against the average this company is at a 20% premium.
At the adjusted group median the market cap would be -16% versus today.
The gap and the implied upside are measured against the median: one richly priced peer moves an average, not a median. The market adjustment uses our coverage medians (US 21.1x, Russia 3.7x, South Africa 5.3x, Kazakhstan 4.6x, India 16.8x, Indonesia 5.3x); it is about where a name is listed, not what it does. Peer multiples come from the nightly rebuild of 2026-10-28; the company's own is live.
| Date | Per share | Details | Status | Source |
|---|---|---|---|---|
| 2026-06-19 | 43 IDR | Ex-dividend: 43 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2025-06-17 | 43 IDR | Ex-dividend: 43 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2024-06-13 | 34 IDR | Ex-dividend: 34 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2023-06-05 | 37 IDR | Ex-dividend: 37 IDR per share | Paid | Yahoo Finance (ex-div) |
| 2022-05-23 | 36 IDR | Ex-dividend: 36 IDR per share | Paid | Yahoo Finance (ex-div) |
KASE: status follows wording in the news headline (paid vs intends to pay). Yahoo: amounts are cash dividends per share on ex-dividend dates (UTC calendar date). stockscope.uz (UZ): amounts are per share in UZS by publication date (not necessarily ex-div).
Investor reporting (IR): https://www.mitrakeluarga.com/investor-relations/
Reporting forms detected in loaded periods: ✓ ✓ ✓ (Balance sheet / Profit or loss (P&L) / Cash flows)
Financial results, valuation multiples (P/E, P/B, EV/EBITDA), profitability and dividend yield of Mitra Keluarga Karyasehat (MIKA) — from primary filings.
See also: Indonesian Stocks (2026): The Cheapest Big Emerging Market · The Cheapest Stocks in the World (2026): What Value Investing Says About Buying Cheap · global valuation map